Division of Malignant Hematology/Cellular Therapy and Transplantation (MH/CTT)
Welcome to the Division of Malignant Hematology/Cellular Therapy and Transplantation. Our specialists are dedicated to providing comprehensive, compassionate and personalized care to our patients, stem cell donors, caregivers and families.
The region’s first bone marrow transplant took place at UC Davis in 1993. Today the MH/CTT Division at the UC Davis Comprehensive Cancer Center is one of the most experienced of its kind in Northern California. We provide a full range of transplant options, including autologous, matched-related and unrelated transplants, and our success rates meet or exceed national averages.
Our department is designated as a National Marrow Donor Program (NMDP) Transplant Center, giving UC Davis patients access to more than 22 million registered stem cell donors worldwide, and more than 600,000 units of donated cord blood. The program participates in national clinical trials through cooperative groups supported by the National Cancer Institute.
We are dedicated to providing comprehensive, compassionate and personalized care to our patients, stem cell donors, caregivers and families. Our collaborative approach to care ensures our patients have the best possible outcomes.
We specialize in the treatment of:
- Transplant for adult patients, including those over 60 years old
- Autologous, allogeneic related and allogeneic unrelated transplants using peripheral blood stem cells, bone marrow and cord blood
- Myeloablative and non-myeloablative (reduced intensity) treatment plans
- Donor lymphocyte infusions
- Phototherapy procedures to treat chronic graft-versus-host disease
- Treatment provided by a collaborative team of stem cell transplant physicians, nurse practitioners and registered oncology nurses
- Care coordination by highly specialized transplant nurse coordinators
- Access to clinical trials
- Pharmacy, social work, nutrition and other patient support services
- Help with arranging temporary housing near the medical center for patient families
- The UC Davis Stem Cell Transplant Program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), which certifies that our program continuously meets or exceeds international standards for stem cell collections, processing and complete patient care from initial evaluation through return to the referring oncologist.
- Our program is designated as a National Marrow Donor Program (NMDP) Transplant Center and meets NMDP’s stringent annual requirements for the performance of unrelated donor transplants.
- The program also participates in National Cancer Institute-sponsored clinical trials and is designated as a Center of Excellence by most health-care insurers.